Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation

13Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The purpose of this review is to provide a framework for the cardiovascular evaluation and management of patients undergoing hematopoietic cell transplantation (HCT). To accomplish this, we have performed an extensive literature review, critically analyzed the available evidence, and developed a set of recommendations to guide best practice. Herein, we discuss the cardiovascular risk profile of patients undergoing HCT along with putative mechanisms of HCT-induced cardiovascular injury. We then present an algorithm for cardiovascular testing and risk mitigation of potential recipients. Last, we address the management of the most prevalent cardiovascular conditions associated with HCT recipients.

Cite

CITATION STYLE

APA

Oliveira, G. H., Al-Kindi, S. G., Guha, A., Dey, A. K., Rhea, I. B., & deLima, M. J. (2021, March 1). Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation. Bone Marrow Transplantation. Springer Nature. https://doi.org/10.1038/s41409-020-01080-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free